These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 22476055

  • 1. Liquid chromatography-tandem mass spectrometric assay for the VEGFR inhibitor cediranib and its primary human metabolite cediranib-N⁺-glucuronide in plasma.
    Sparidans RW, Durmus S, Xu N, Schinkel AH, Schellens JH, Beijnen JH.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May 01; 895-896():169-73. PubMed ID: 22476055
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Liquid chromatography-tandem mass spectrometric assay for sorafenib and sorafenib-glucuronide in mouse plasma and liver homogenate and identification of the glucuronide metabolite.
    Sparidans RW, Vlaming ML, Lagas JS, Schinkel AH, Schellens JH, Beijnen JH.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan 15; 877(3):269-76. PubMed ID: 19117812
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Liquid chromatography-tandem mass spectrometric assay for the light sensitive tyrosine kinase inhibitor axitinib in human plasma.
    Sparidans RW, Iusuf D, Schinkel AH, Schellens JH, Beijnen JH.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec 15; 877(32):4090-6. PubMed ID: 19910267
    [Abstract] [Full Text] [Related]

  • 7. Liquid chromatography-tandem mass spectrometric assay for the PARP-1 inhibitor olaparib in combination with the nitrogen mustard melphalan in human plasma.
    Sparidans RW, Martens I, Valkenburg-van Iersel LB, den Hartigh J, Schellens JH, Beijnen JH.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul 01; 879(21):1851-6. PubMed ID: 21622034
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Liquid chromatography-tandem mass spectrometric assay for diclofenac and three primary metabolites in mouse plasma.
    Sparidans RW, Lagas JS, Schinkel AH, Schellens JH, Beijnen JH.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep 01; 872(1-2):77-82. PubMed ID: 18674973
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Liquid chromatography-tandem mass spectrometric assay for the mutated BRAF inhibitor vemurafenib in human and mouse plasma.
    Sparidans RW, Durmus S, Schinkel AH, Schellens JH, Beijnen JH.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar 15; 889-890():144-7. PubMed ID: 22386128
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.
    Figurski MJ, Korecka M, Fields L, Waligórska T, Shaw LM.
    Ther Drug Monit; 2009 Dec 15; 31(6):717-26. PubMed ID: 19809389
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rapid determination of gefitinib and its main metabolite, O-desmethyl gefitinib in human plasma using liquid chromatography-tandem mass spectrometry.
    Wang LZ, Lim MY, Chin TM, Thuya WL, Nye PL, Wong A, Chan SY, Goh BC, Ho PC.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul 15; 879(22):2155-61. PubMed ID: 21703945
    [Abstract] [Full Text] [Related]

  • 17. Simultaneous determination of thienorphine and its active metabolite thienorphine glucuronide in rat plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic studies.
    Kong Q, Qiao J, Wang X, Yuan S, Zhang Z, Gong Z, Ruan J.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov 01; 859(1):52-61. PubMed ID: 17933594
    [Abstract] [Full Text] [Related]

  • 18. Liquid chromatography-tandem mass spectrometric assay for the PARP inhibitor rucaparib in plasma.
    Sparidans RW, Durmus S, Schinkel AH, Schellens JH, Beijnen JH.
    J Pharm Biomed Anal; 2014 Jan 01; 88():626-9. PubMed ID: 24216281
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Liquid chromatography-tandem mass spectrometric assay for the tyrosine kinase inhibitor afatinib in mouse plasma using salting-out liquid-liquid extraction.
    Sparidans RW, van Hoppe S, Rood JJ, Schinkel AH, Schellens JH, Beijnen JH.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb 15; 1012-1013():118-23. PubMed ID: 26826475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.